HomeInsightsStock Comparison

Panacea Biotec Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Panacea Biotec Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Panacea Biotec Ltd is ₹ 451.8 as of 13 Jun 15:30.
  • The P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Panacea Biotec Ltd changed from ₹ 670.7 crore on March 2020 to ₹ 742.97 crore on March 2024 . This represents a CAGR of 2.07% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Panacea Biotec Ltd for the Mar '25 is ₹ 168.83 crore as compare to the Dec '24 revenue of ₹ 169.88 crore. This represent the decline of -0.62% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Panacea Biotec Ltd for the Mar '25 is ₹ 9.42 crore as compare to the Dec '24 ebitda of ₹ 14.35 crore. This represent the decline of -34.36% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Panacea Biotec Ltd changed from ₹ 10.98 crore to ₹ -1.99 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Panacea Biotec Ltd News Hub

News

Panacea Biotec announces inclusion of EmulsiPan into prestigious CEPI Adjuvant Library

Panacea Biotec announced the listing of EmulsiPan in the CEPI (Coalition for Epidemic Prep...

Read more

03 Jun 2025 12:08

News

Panacea Biotec declare Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2025...

Read more

26 May 2025 17:09

News

Panacea Biotec to announce Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

01 Feb 2025 10:27

News

Panacea Biotec Pharma launches 'NikoMom' brand of baby diapers and wipes

Panacea Biotec announced that the company's wholly owned subsidiary, Panacea Biotec Pharma...

Read more

03 Jan 2025 15:24

News

Panacea Biotec announces investment in Panacea Biotec Inc.

Panacea Biotec announced that the company's material subsidiary, Panacea Biotec Pharma (PB...

Read more

28 Dec 2024 14:00

News

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

The company will supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa ...

Read more

26 Dec 2024 10:30

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma updates on US FDA inspection

Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing ...

Read more

14 Jun 2025 12:11

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Panacea Biotec Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Panacea Biotec Ltd is 2,767 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 405,175 Cr

What are the key factors driving the stock performance of Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd?

As of June 14, 2025, the Panacea Biotec Ltd stock price is INR ₹451.8. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1688.7.

How do dividend payouts of Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Panacea Biotec Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions